These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 2116504)

  • 1. Drug resistance in tuberculosis.
    al-Orainey IO
    J Chemother; 1990 Jun; 2(3):147-51. PubMed ID: 2116504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resistance to antituberculosis drugs in rural South Africa: rates, patterns, risks, and transmission dynamics.
    Wilkinson D; Pillay M; Davies GR; Sturm AW
    Trans R Soc Trop Med Hyg; 1996; 90(6):692-5. PubMed ID: 9015521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug-resistance of Mycobacterium tuberculosis in Patras, Greece.
    Trakada G; Tsiamita M; Spiropoulos K
    Monaldi Arch Chest Dis; 2004; 61(1):65-70. PubMed ID: 15366340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dosing regimens in the treatment of tuberculosis.
    Blom-Bülow B
    Scand J Infect Dis Suppl; 1990; 74():258-61. PubMed ID: 2129066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effectiveness and problems of PZA-containing 6-month regimen for the treatment of new pulmonary tuberculosis patients].
    Wada M
    Kekkaku; 2001 Jan; 76(1):33-43. PubMed ID: 11211781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Response to the short-course chemotherapy in patients presenting initial resistance].
    Mitchison DA
    Bull Int Union Tuberc; 1985; 60(1-2):41-3. PubMed ID: 2416375
    [No Abstract]   [Full Text] [Related]  

  • 7. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
    API Consensus Expert Committee
    J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular genetics of drug resistance in Mycobacterium tuberculosis.
    Zhang Y; Young D
    J Antimicrob Chemother; 1994 Sep; 34(3):313-9. PubMed ID: 7829406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary antituberculosis drug resistance and acquired rifampicin resistance in Gujarat, India.
    Trivedi SS; Desai SG
    Tubercle; 1988 Mar; 69(1):37-42. PubMed ID: 3140458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antituberculosis drug resistance in Keelung area-1993 to 1994.
    Hua CC; Chang LC; Yu TJ; Lee N; Shieh WB
    Changgeng Yi Xue Za Zhi; 1996 Jun; 19(2):107-14. PubMed ID: 8828251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. From the Centers for Disease Control and Prevention. Initial therapy for tuberculosis in the era of multidrug resistance: recommendations of the Advisory Council for the Elimination of Tuberculosis.
    JAMA; 1993 Aug; 270(6):694-8. PubMed ID: 8336361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of initial drug resistance on the response to short-course chemotherapy of pulmonary tuberculosis.
    Mitchison DA; Nunn AJ
    Am Rev Respir Dis; 1986 Mar; 133(3):423-30. PubMed ID: 2420242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Initial resistance to streptomycin, isoniazid, thiacetazone, rifampicin and ethambutol in bacilliferous tuberculosis in Maniema, Zaire].
    De Caluwé P; Everaerts MC; Dufour B; wa Tshalumba M
    Ann Soc Belg Med Trop; 1989 Jun; 69(2):143-7. PubMed ID: 2508582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Present chemotherapy for tuberculosis.
    Dutt AK; Stead WW
    J Infect Dis; 1982 Nov; 146(5):698-704. PubMed ID: 6813386
    [No Abstract]   [Full Text] [Related]  

  • 15. Longitudinal whole genome analysis of pre and post drug treatment Mycobacterium tuberculosis isolates reveals progressive steps to drug resistance.
    Datta G; Nieto LM; Davidson RM; Mehaffy C; Pederson C; Dobos KM; Strong M
    Tuberculosis (Edinb); 2016 May; 98():50-5. PubMed ID: 27156618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How drug resistance emerges as a result of poor compliance during short course chemotherapy for tuberculosis.
    Mitchison DA
    Int J Tuberc Lung Dis; 1998 Jan; 2(1):10-5. PubMed ID: 9562106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overview of anti-tuberculosis (TB) drugs and their resistance mechanisms.
    Shi R; Itagaki N; Sugawara I
    Mini Rev Med Chem; 2007 Nov; 7(11):1177-85. PubMed ID: 18045221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Azole antifungals as novel chemotherapeutic agents against murine tuberculosis.
    Ahmad Z; Sharma S; Khuller GK
    FEMS Microbiol Lett; 2006 Aug; 261(2):181-6. PubMed ID: 16907718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implications of multidrug resistance for the future of short-course chemotherapy of tuberculosis: a molecular study.
    Heym B; Honoré N; Truffot-Pernot C; Banerjee A; Schurra C; Jacobs WR; van Embden JD; Grosset JH; Cole ST
    Lancet; 1994 Jul; 344(8918):293-8. PubMed ID: 7914261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Initial therapy for tuberculosis in the era of multidrug resistance. Recommendations of the Advisory Council for the Elimination of Tuberculosis.
    MMWR Recomm Rep; 1993 May; 42(RR-7):1-8. PubMed ID: 8413157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.